Cyclosporine microemulsion formulation (Neoral) in transplantation: pharmacokinetic/pharmacodynamic relationships.
Mueller
E A
EA
Department of Clinical Research and Biostatistics, Novartis Pharma AG, Basel, Switzerland.
Niese
D
D
Mellein
B
B
D000284:Administration, Oral; D000328:Adult; D001794:Blood Pressure / Q000187:drug effects; D002648:Child; D003404:Creatinine / Q000097:blood; D016572:Cyclosporine / Q000493:pharmacokinetics* / Q000494:pharmacology / Q000627:therapeutic use*; D004655:Emulsions; D006084:Graft Rejection / Q000453:epidemiology / Q000517:prevention & control; D006801:Humans; D007166:Immunosuppressive Agents / Q000493:pharmacokinetics* / Q000494:pharmacology / Q000627:therapeutic use*; D016030:Kidney Transplantation / Q000276:immunology; D016032:Randomized Controlled Trials as Topic; D012044:Regression Analysis; D014181:Transplantation Immunology
D004655:Emulsions; D007166:Immunosuppressive Agents; D016572:Cyclosporine; D003404:Creatinine